CIN 约3条结果 (0.82秒)

期刊论文
放弃医学治疗临终最晚期癌症患者全营养食疗研究报告
Department of Full-scale Nutrition Diet Therapy and Cancer Research, Beijing Rongxiang Institute of Regeneration Medicine 全营养食疗攻克癌症研究室; 中国烧伤创疡杂志 2008

摘要:目的:通过对放弃医学治疗临终最晚期癌症患者进行全营养食疗,提供给患者所有正常细胞活动所需的全部营养成分,包括碳水化合物、蛋白质(全部氨基酸)、脂肪酸(多种)、维生素、矿物质、微量元素和干细胞营养物质(简称再生物质),同时结合生物钟饮食计划,使人体中80%的细胞按其自身的活动或休息所需的不同营养,得到不同的营养成分。最大可能地保障各种营养食物充分消化、吸收和利用,使所有正常细胞得到强壮,实现组织器官再生和功能恢复,抵抗癌细胞对正常细胞的伤害,起到营养抗癌的目的。探索全营养食疗对临终最晚期癌症患者具有抗癌效果的可能性。方法:患者或家属在网上注册并填写全营养食疗申请表,上传病历资料。专家组根据病历资料进行审核,将符合研究条件的患者纳入本研究,提供美宝牌胃肠胶囊和膳素,患者或家属按要求1d~3d汇报病情及每餐的饮食成分和量,专家在网上结合生物钟饮食计划给予饮食指导和解答患者、家属咨询。结果:1.参加全营养食疗超过15d的患者总的存活率73.04%,死亡率26.96%最晚期癌症临终期生存率44.44%,死亡率55.56%;最晚期癌症进展期生存率84.00%,死亡率16.00%;最晚期癌症相对稳定期生存率100%。2.参加全营养食疗超过14月的患者总的存活率72.91%,死亡率27.09%。最晚期癌症临终期生存率44.44%,死亡率55.56%;最晚期癌症进展期生存率83.87%,死亡率16.13%;最晚期癌症相对稳定期生仔率100%。3.参加全营养食疗超过2个月的患者总的存活率71.58%,死亡率28.42%。最晚期癌症临终期生存率41.67%,死亡率58.33%;最晚期癌症进展期生存率83.48%,死亡率16.52%;最晚期癌症相对稳定期生存率100%。4.参加全营养食疗超过3个月的患者总的存活率67.70%,死亡率32.30%最晚期癌症临终期生存率40.00%,死亡率60.00%;最晚期癌症进展期生存率79.35%,死亡率20.65%;最晚期癌症相对稳定期生存率100%。5.参加全营养食疗超过4个月的患者总的生存率57.35%,死亡率42.65%。最晚期癌症临终期生存率33.33%,死亡率66.67%;最晚期癌症进展期生存率61.54%,死亡率38.46%;最晚期癌症相对稳定期生存率100%。结论:无论是总的生存率,还是各期最晚期癌症和各种癌症的生存率都明显提高,能明显改善患者的胃肠道功能,提高部分患者的睡眠质量,增加...

胃肠修复
期刊论文
全国第九届烧伤创疡康复明星和精英医生评选结果公告
Medicine, The Chinese Burn Association of the Integration of Traditional Chinese and Western 中国烧伤创疡杂志 2012

摘要:<正>在第十二届全同烧伤创疡学术会议暨首届国际烧伤会议上,国内外的烧伤创疡专家共同评选出了第九届全国烧伤康复明星和第三届创疡康复明星及精英医生,现公布结果。烧伤创疡康复明星的评选是用临床疗效、患者满意度等评价医生应用烧伤再生医疗技术治疗患者的技术水平的,这一科学成就的评价方式避免了人为的评价因素,完全客观的展示医生的临床医疗水平譬如,如果医

期刊论文
Scar Formation, Healing Stages, and Advanced Treatment Strategies – Review
Do, Monika Kienanh; Van, Marcin Mikusek-Pham; Zaliwska, Dominika; Kraszkiewicz, Adrianna; Paduszyńska, Natalia; Gonciarz, Marta Justyna; Adamiec, Dominika Karolina; D?browska, Anna; Kamińska, Monika Anna; Czach, Magdalena Warsaw Medical University, Warsaw, Poland; University Clinical Center Medical University of Warsaw, 02-097 Warsaw, Poland; University Clinical Hospital in Poznań, Przybyszewskiego 49, 60-355 Poznań, Poland; Dr Anna Gostynska Wolski Hospital, Independent Public Health Care Institution, Marcina Kasprzaka 17, 01-211 Warsaw, Poland; Independent Public Clinical Hospital Witolda Or?owskiego, Czerniakowska 231, 00-416 Warsaw, Poland; LUX MED, Post?pu 21C, 02-676 Warsaw, Poland Quality in Sport 2024

摘要:Introduction and Aim of the Study: Scarring is a major concern in clinical dermatology, affecting individuals' quality of life due to both physical and psychological impacts. This review aims to explore the pathophysiology of various scar types—hypertrophic, keloid, and atrophic—and evaluate the effectiveness of current and emerging treatments to inform better clinical practices and therapeutic strategies. Description of the State of Knowledge: Scar formation involves complex biological processes: inflammation, proliferation, and remodeling. The nature of the scar varies with the underlying cause and biological response, influenced by genetic factors, skin tension, and environmental elements such as UV exposure. Recent advances in treatments range from surgical techniques to laser therapy and biological agents like cytokines. Conclusion: The studies reviewed underscore the complexity of scar management, influenced by diverse genetic, biological, and environmental factors. No single treatment is universally effective, but a combination of preventative and therapeutic strategies shows the best promise.

再生医学汇
AI Research Assistant

您好,我是再生医学汇AI助手

您的专业再生医学研究助理,准备好探索生命科学了